AU5617090A - The use of xylan polyhydrogensulfates fro the therapy of disorders based on cell proliferation - Google Patents

The use of xylan polyhydrogensulfates fro the therapy of disorders based on cell proliferation

Info

Publication number
AU5617090A
AU5617090A AU56170/90A AU5617090A AU5617090A AU 5617090 A AU5617090 A AU 5617090A AU 56170/90 A AU56170/90 A AU 56170/90A AU 5617090 A AU5617090 A AU 5617090A AU 5617090 A AU5617090 A AU 5617090A
Authority
AU
Australia
Prior art keywords
polyhydrogensulfates
xylan
fro
therapy
cell proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56170/90A
Inventor
Jorg Czech
Gerhard Dickneite
Renato V. Larocca
Charles E. Myers
Elmar Schrinner
Hans-Harald Sedlacek
Cy Stein
Anton Wellstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU5617090A publication Critical patent/AU5617090A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU56170/90A 1989-06-02 1990-05-31 The use of xylan polyhydrogensulfates fro the therapy of disorders based on cell proliferation Abandoned AU5617090A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3917982 1989-06-02
DE3917982A DE3917982A1 (en) 1989-06-02 1989-06-02 USE OF XYLANPOLYHYDROGENSULFATES FOR THE THERAPY OF CELL PROBLEMATION-RELATED DISEASES

Publications (1)

Publication Number Publication Date
AU5617090A true AU5617090A (en) 1990-12-06

Family

ID=6381904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56170/90A Abandoned AU5617090A (en) 1989-06-02 1990-05-31 The use of xylan polyhydrogensulfates fro the therapy of disorders based on cell proliferation

Country Status (7)

Country Link
EP (1) EP0400586A1 (en)
JP (1) JPH0320225A (en)
KR (1) KR910000170A (en)
AU (1) AU5617090A (en)
CA (1) CA2018133A1 (en)
DE (1) DE3917982A1 (en)
PT (1) PT94211A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
WO2009057139A2 (en) 2007-10-29 2009-05-07 Natco Pharma Limited Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
FI126211B (en) * 2012-11-09 2016-08-15 Montisera Ltd Wood-based hemicelluloses for use in treating symptoms and diseases of the lower urinary tract
JP6225321B1 (en) 2016-08-31 2017-11-08 王子ホールディングス株式会社 Method for producing polysulfate pentosan
CN111148749A (en) 2016-08-31 2020-05-12 王子控股株式会社 Production method of acidic xylo-oligosaccharide and acidic xylo-oligosaccharide
JP6281659B1 (en) 2017-02-28 2018-02-21 王子ホールディングス株式会社 Polysulfate pentosan, pharmaceutical composition and anticoagulant
EP3632451A4 (en) 2017-05-31 2021-03-10 Oji Holdings Corporation Moisturizing topical preparation
WO2019054344A1 (en) 2017-09-12 2019-03-21 王子ホールディングス株式会社 Pentosan polysulfate and method for producing pentosan polysulfate
CN111511773B (en) 2017-12-20 2023-01-13 王子控股株式会社 Pentosan polysulfate and medicament containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543145B1 (en) * 1983-03-24 1986-10-17 Sanofi Sa NOVEL XYLAN SULPHATES, THEIR PREPARATION PROCESS AND THEIR ANTI-THROMBOTIC AND HYPOLIPEMIC ACTIVITY
DE3601136A1 (en) * 1986-01-16 1987-07-23 Max Planck Gesellschaft INHIBITORS OF REVERSE TRANSCRIPTASE FOR PROPHYLAXIS AND THERAPY OF RETROVIRUS INFECTIONS IN MAMMALS

Also Published As

Publication number Publication date
DE3917982A1 (en) 1990-12-06
KR910000170A (en) 1991-01-29
JPH0320225A (en) 1991-01-29
EP0400586A1 (en) 1990-12-05
PT94211A (en) 1991-02-08
CA2018133A1 (en) 1990-12-02

Similar Documents

Publication Publication Date Title
AU4969885A (en) Medical spray device
AU1928388A (en) Surgical dressing
GB2199226B (en) Cutter-trimmer of the walk-behind type
AU2421084A (en) Proppant including ceramic spheres with micropores
AU580586B2 (en) Ophthalmic solution
AU565403B2 (en) Rotatable hydrotherapy nozzle
AU5541786A (en) Games tables
AU5010685A (en) Human tumor necrosis factor
AU5617090A (en) The use of xylan polyhydrogensulfates fro the therapy of disorders based on cell proliferation
AU558481B2 (en) Orthopedic foot splint with swivel
AU624067B2 (en) Preparation suitable for use in the treatment of enteric disorders
AU591903B2 (en) Novel treatment
GB8623003D0 (en) Orthopaedic chair
AU582409B2 (en) Microprocessor with option area facilitating interfacing with peripheral devices
AU4619893A (en) Substituted phenols, processes for their preparation and their use for the treatment of disorders caused by cell proliferation
AU1427188A (en) Elastic bandage
AU6075886A (en) New Benzamides
AU2905984A (en) 4-dl-alkyl ester-alpha-alaninyl-6-chloro-s-triazines and the use thereof as herbicides
AU1346488A (en) Arginine-depleted human tumor necrosis factor
AU591683B2 (en) Novel treatment
AU8269787A (en) Flyslag treatment
AU7481287A (en) Therapeutic use of tin diiododeuteroporphyrin
AU6142686A (en) Emergence-promoting rhizobacteria
AU3062089A (en) Apparatus for use in the manufacture of batteries
GB8622476D0 (en) Compression bandage